Envision Pharma Group has launched its second solution for the emerging EnvisionOne platform. EnvisionOne Vantage brings unique industry benchmarking insights and functionality to the market for the first time. It empowers life sciences companies to optimize their publication strategies and maximize the impact of their clinical research through data-driven insights.
The new solution enables medical affairs professionals to benchmark their publication performance against other pharmaceutical companies, providing crucial competitive intelligence. EnvisionOne Vantage helps identify factors that may influence submission rates or acceptance times and highlight areas for improvement. This data-driven approach provides valuable insights for strategic adjustments to publication strategies, ultimately maximizing research impact and ensuring a competitive edge.
EnvisionOne Vantage can also assist with the fast and effective identification and engagement of key opinion leaders to build important advocacy networks.
Later in 2025, AI-powered predictive analytics will also be available within the EnvisionOne Vantage solution. Users will be able to leverage predictive analytics to effectively forecast project timelines – enabling efficient resource allocation – and predict patient responses to engagement efforts.
Jim Streeter, President of Technology and Chief Technology Officer at Envision Pharma Group, said: “This new release brings users another level of intelligence capabilities and analytics expertise. Medical affairs professionals will be able to access real-time data and benchmarking against industry standards – insights that just aren’t available elsewhere. With the addition of predictive analytics later this year, users will be able to make informed recommendations by forecasting trends and anticipating outcomes.
“The new solution will empower our clients to make informed strategic and operational decisions, utilizing insights to demonstrate the value of medical affairs activities and secure internal resources for future projects. At a time when escalating costs and increasing workflow complexity continue to drive the need for advanced technology platforms, the release of this solution ahead of the highly anticipated EnvisionOne platform is a real game changer for evidence-based decision-making, streamlining processes, and driving better outcomes for patients.”
EnvisionOne is Envision Pharma Group’s next-generation data platform, developed specifically for medical affairs and grounded in a deep understanding of complex workflows, compliance needs, and a mission to bring life-changing products to market. In 2024, Envision launched EnvisionOne Insights, enabling customers to transform how they access and optimize their data using Envision’s suite of technology products.